V. Gómez-Vallejo et al. / Tetrahedron Letters 51 (2010) 2990–2993
2993
2. Grisham, M. B.; Jourd’Heuil, D.; Wink, D. A. Am. J. Physiol. 1999, 276, G-315–G-
321.
3. Al-Sa’doni, H. H.; Ferro, A. Mini-Rev. Med. Chem. 2005, 5, 247–254.
4. Khan, M.; Jatana, M.; Elango, C.; Paintlia, A. S.; Singh, A. K.; Singh, I. Nitric Oxide
2006, 15, 114–124.
5. Al-Sa’doni, H.; Ferro, A. Clin. Sci. 2000, 98, 507–520.
6. Jaworski, K.; Kinard, F.; Goldstein, D.; Holvoet, P.; Trouet, A.; Schneider, Y.-J.;
Remacle, C. Eur. J. Pharmacol. 2001, 425, 11–19.
7. Llop, J.; Gómez-Vallejo, V.; Bosque, M.; Quincoces, G.; Peñuelas, I. Appl. Radiat.
Isot. 2009, 67, 95–99.
8. Gómez-Vallejo, V.; Kato, K.; Hanyu, M.; Minegishi, K.; Borrell, J. I.; Llop, J. Bioorg.
Med. Chem. Lett. 2009, 19, 1913–1915.
9. The scheme of the automated system, the characteristics of the individual
components and details about synthetic steps are included as Supplementary
data.
(185 MBq/
l
mol) in the case of 5, probably due to the presence of
ꢁ
ꢁ
NO3 and/or NO2 as impurities in the hydrochloric acid solution.
Stability tests performed on 1 and 3–6 showed that, in all cases,
radiochemical purities after 48 min (from end of synthesis) were
above 97% (Table 3). For compound 2, radiochemical purity quickly
decreased with time (results not shown) confirming the instability
of S-[13N]nitrosothiophenol; different additives were assayed to
improve stability with poor results.
To the best of our knowledge, the synthesis of S-[13N]nitrosothi-
ols has been reported previously only by us7 and by Vavrek and
Mulholland,18 who investigated the formation of water-soluble S-
[
13N]nitrosothiols following a similar procedure. In that case, puri-
10. Cadmium (20 g., granular, 5–20 mesh) was introduced in a glass column
(10 mm id, 8 cm in length) and sequentially washed with 1 M HCl (2 ꢂ 20 mL),
distilled water (3 ꢂ 20 mL), 0.5 M aqueous CuSO4 solution (2 ꢂ 20 mL), 0.1 M
aqueous NH4Cl solution (2 ꢂ 20 mL), and distilled water (3 ꢂ 20 mL). The
column showed excellent reductive properties for up to 10 consecutive runs
within one day. Reconditioning on a daily basis ensured optimal performance
for up to 100 runs.
fication step was not performed and the chemical purity of final
radiotracers was not precisely reported.
In the work we are presenting here, decay corrected radiochem-
ical yield for the synthesis of 5 (33.8 3.1%) is slightly higher than
the one reported in our previous work7 (24.2%). Radiochemical
purity is somewhat higher than in the previous work (99.2 0.2%
vs 96.4 0.6%) and the method has been extended to the prepara-
tion of non water-soluble S-[13N]nitrosothiols. Therefore, the gen-
eral procedure here reported should allow the preparation of a
wide range of S-[13N]nitrosothiols with high chemical and radio-
chemical purity.
11. Precursors for the radiosynthesis of S-[13N]nitrosothiols 1–5 were purchased
from Sigma–Aldrich and used without further purification. For the synthesis of
2-(N-acetyl-D-penicillamido)-2-deoxy-1,3,4,6-tetra-O-acetyl-b-D-glucopyranose
(precursor for 6), the methodology described in Ref. 12 was followed.
12. Butler, A. R.; Greig, I. R.; Megson, I. L. WO/1998/020015, 1998.
13. For analytical HPLC, an Agilent 1200 Series HPLC system with a multiple
wavelength detector (k = 220 nm) and a radiometric detector was used. A
Mediterranean SeaRP-18 column (5 lm, 150 mm, 4.6 mm) was used as
stationary phase. For compounds 1–4 and 6, water/methanol/acetonitrile
(10:15:75) was used as mobile phase at a flow rate of 1 mL/min. For compound
5, aqueous TFA solution/acetonitrile (95:5) was used at a flow rate of 1 mL/min.
14. Wang, K.; Hou, Y.; Zhang, W.; Ksebati, M. B.; Xian, M.; Cheng, J. P.; Wang, P. G.
Bioorg. Med. Chem. Lett. 1999, 9, 2897–2902.
Acknowledgments
The authors would like to thank Dr. Peñuelas (Nuclear Medicine
Department, Clínica Universitaria de Navarra) for developing and
transferring to our research group the original idea of synthesizing
S-[13N]nitrosothiols. The authors also thank the Departamento de
Industria, Comercio y Turismo of the Vasc Government for financial
support.
15. For semi-preparative HPLC, an isocratic pump (Knauer) with a radiometric
detector was used. A Mediterranean Sea18 column (5 lm, 250 mm, 10 mm)
was used as stationary phase. For compounds 1–4 and 6, water/ethanol/
acetonitrile (10:15:75) was used as mobile phase at a flow rate of 6 mL/min.
For compound 5, aqueous TFA solution/ethanol (85:15) was used at a flow rate
of 4 mL/min.
16. UPLC/MS analyses were performed using an AQUITY UPLC separation module
coupled to a LCT TOF Premier XE mass spectrometer (Waters, Manchester, UK).
An Acquity BEH C18 column (1.7 lm, 5 mm, 2.1 mm) was used as stationary
phase. The elution buffers were A (methanol and 0.1% formic acid) and B
(water and 0.1% formic acid). The column was eluted with a linear gradient
consisted of 95% A to 1% over 2.5 min, 1% over 2.5–3.5 min, returned to 95 for
0.5 min and kept for a further 1 min. Total run was 5 min, injection volume was
Supplementary data
Supplementary data associated with this article can be found, in
5 lL and the flow rate 600 lL/min. Detection was performed in positive ion
mode in the range of 50–1000, with a scan time of 1 s and a delay time of 0.1 s
in centered mode. GSNO was detected as protonated molecule (m/z = 377.08,
retention time = 0.81 min) and RIG was detected as sodium adduct (m/z =
572.15, retention time = 1.78 min).
References and notes
17. Scenario 1: as reported in Ref. 13; scenario 2: as reported in Ref. 16.
18. Vavrek, M. T.; Mulholland, G. K. J. Labelled. Compd. Radiopharm. 1995, 37, 118.
1. Lundberg, J. O.; Weitzberg, E.; Gladwin, M. T. Nat. Rev. Drug Disc. 2008, 7, 156–
167.